Related Experiment Video
Updated: Feb 24, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Interventional and surgical occlusion of the left atrial appendage
Etem Caliskan1,2, James L Cox3, David R Holmes4
1Department of Cardiovascular Surgery, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Insights
Atrial fibrillation (AF) increases stroke risk. Left atrial appendage (LAA) occlusion offers an alternative to medication for stroke prevention in AF patients, but complications require further study.
Area of Science:
- Cardiology
- Vascular Medicine
- Interventional Cardiology
Background:
- Atrial fibrillation (AF) is a common heart arrhythmia globally, significantly increasing stroke risk due to thromboembolic events.
- The left atrial appendage (LAA) is the main source of these dangerous blood clots in nonvalvular AF patients.
- Stroke prevention in AF is a critical clinical challenge, driving innovation in LAA-targeted therapies.
Purpose of the Study:
- To review current pharmacological and mechanical techniques for left atrial appendage (LAA) occlusion.
- To discuss the clinical evidence supporting various LAA occlusion strategies for stroke prevention in nonvalvular AF.
- To examine the challenges and future directions in LAA occlusion management.
Main Methods:
- Review of existing literature on LAA occlusion techniques.
- Analysis of clinical data from randomized trials and registries for percutaneous LAA occlusion devices.
- Discussion of pharmacological and interventional approaches to LAA management.
Main Results:
- Percutaneous LAA occlusion devices show promise as an alternative to pharmacological stroke prevention in AF.
- Robust clinical data support the efficacy of some LAA occlusion devices.
- Complications like periprocedural issues, device-related thrombi, and LAA leaks are current limitations.
Conclusions:
- LAA occlusion is a viable alternative for stroke prevention in high-risk nonvalvular AF patients.
- Further research is needed to address the long-term implications of periprocedural complications and device-related issues.
- Optimizing LAA occlusion techniques and management is crucial for broader clinical acceptance and improved patient outcomes.
Abstract:
With a steadily increasing prevalence, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and an independent risk factor for stroke caused by thromboembolic events. The left atrial appendage (LAA) is the primary source of thromboemboli in patients with nonvalvular AF who have a stroke. Novel strategies (such as mechanical and nonpharmacological intervention) targeting the LAA in patients with AF for stroke prevention have become a major focus during the past decade. Some devices for percutaneous LAA occlusion are supported by robust clinical data obtained from randomized trials or large registries, and are a valid alternative to pharmacological stroke prevention. However, the incidence of periprocedural complications and the presence of device-related thrombi or residual LAA leaks, whose long-term clinical implications are still unknown, are limiting factors in wider acceptability of these techniques. In this Review, we discuss the available techniques for LAA occlusion in patients with nonvalvular AF at high risk of stroke. We describe the pharmacological and mechanical approaches to LAA occlusion, and provide the current clinical evidence for various strategies. We particularly focus on the current management of the LAA, and discuss the challenges and future implications of the available approaches to LAA occlusion.
Related Concept Videos
01:24Cardiac Catheterization III: Left Heart Catheterization
01:25Aortic Regurgitation III: Medical Management
01:26Aneurysm III: Interprofessional Care